The Commonwealth Serum Laboratories was established in Australia in 1916 to service the health needs of a nation isolated by war. Over the ensuing years CSL provided Australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines against influenza, polio and other infectious diseases. CSL Limited was incorporated in 1991 and listed on the Australian Securities Exchange (ASX) in 1994.
Today, CSL comprises businesses with longstanding, specialized expertise: CSL Behring, a global leader in rare and serious diseases; CSL Seqirus, one of the largest influenza vaccine providers in the world; CSL Plasma, the world's largest plasma collection company; and, most recently, CSL Vifor, a leader in iron deficiency and nephrology. Together, our combined and robust histories are delivering a healthier today and a better tomorrow for patients and people everywhere.
"Vita" means life. At CSL Behring, our focus is on developing and delivering biotherapies that save lives. Vita is the place where we share those stories, to provide insight about, and awareness of, the ever-evolving promise of biotechnology.
Vita’s audience includes patients and their families, health care providers, the media, our people and other key stakeholders. Our content is rooted in great storytelling: well-told narratives; clear, explanatory prose; and compelling photos, video and infographics. You can find these stories on the Vita section of our website and on social media.
Precious Raw Material: Plasma
A subsidiary of CSL Behring, CSL Plasma operates one of the world's largest and most sophisticated plasma collection networks, with more than 330 plasma collection centers in the U.S., Europe and China.Visit CSL Plasma